Objective The first product that AURA will launch to the market will be OSCANN, a diagnosis platform that will allow better, fasterand more accurate diagnosis of neurological disorders affecting Europe’s population in general, but specially youngsters(e.g. ADHD) and elders (e.g. Parkinson). OSCANN allows for the measurement and analysis of ocular and oculocephalicmovements (OM/OCM) and combines the result with data obtained from other sources (clinical histories, medicalexplorations, complementary tests and biomarkers) using Artificial Intelligence (AI) techniques to improve significantly thequality of medical diagnosis in early stages. Fields of science natural sciencescomputer and information sciencesartificial intelligencenatural sciencescomputer and information sciencessoftwaremedical and health sciencesbasic medicineneurologydementiaalzheimermedical and health sciencesclinical medicinepsychiatrymedical and health sciencesbasic medicineneurologyparkinson Programme(s) H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme H2020-EU.3.1.4. - Active ageing and self-management of health H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument H2020-EU.3.1.6. - Health care provision and integrated care Topic(s) SMEInst-06-2016-2017 - Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well Call for proposal H2020-SMEInst-2016-2017 See other projects for this call Sub call H2020-SMEINST-1-2016-2017 Funding Scheme SME-1 - SME instrument phase 1 Coordinator AURA INNOVATIVE ROBOTICS, SL Net EU contribution € 50 000,00 Address Calle yarumal 2 1 a 28045 Madrid Spain See on map Region Comunidad de Madrid Comunidad de Madrid Madrid Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 21 429,00